Skip to main content
OpenTrials
Completed

NCT Number: NCT03184519

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Test

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IVI Valencia

Valencia, 46003, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent
  • Patients undergoing their first or second IVF-ET cycle
  • Age 18-45 years
  • Use of Ovitrelle for final follicular maturation and luteinization
  • Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation)

Exclusion criteria

  • Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother)
  • Canceled IVF cycles
  • GnRH agonist triggering cycles in the case of fresh ET.

Treatment and study plan

pregnancy test

Diagnostic Test

Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.

Primary outcomes

  1. Number of Participants With Early Detection of Pregnancy

    Time frame: One month

    Detection of Pregnancy on earlier dates (before day-11 after Embrio transfer)

Sponsors and collaborators

Lead sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA

Other

Registry information

Official study title

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy After In-vitro Fertilization and Embryo Transfer.

Acronym: hyperPOC

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jun 12, 2017
Registry last updated
Aug 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.